Literature DB >> 19956109

The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

C Julier1, B Akolkar, P Concannon, G Morahan, C Nierras, A Pugliese.   

Abstract

Candidate gene studies have long been the principal method for identification of susceptibility genes for type I diabetes (T1D), resulting in the discovery of HLA, INS, PTPN22, CTLA4, and IL2RA. However, many of the initial studies that relied on this strategy were largely underpowered, because of the limitations in genomic information and genotyping technology, as well as the limited size of available cohorts. The Type I Diabetes Genetic Consortium (T1DGC) has established resources to re-evaluate earlier reported genes associated with T1D, using its collection of 2298 Caucasian affected sib-pair families (with 11 159 individuals). A total of 382 single-nucleotide polymorphisms (SNPs) located in 21 T1D candidate genes were selected for this study and genotyped in duplicate on two platforms, Illumina and Sequenom. The genes were chosen based on published literature as having been either 'confirmed' (replicated) or not (candidates). This study showed several important features of genetic association studies. First, it showed the major impact of small rates of genotyping errors on association statistics. Second, it confirmed associations at INS, PTPN22, IL2RA, IFIH1 (earlier confirmed genes), and CTLA4 (earlier confirmed, with distinct SNPs) loci. Third, it did not find evidence for an association with T1D at SUMO4, despite confirmed association in Asian populations, suggesting the potential for population-specific gene effects. Fourth, at PTPN22, there was evidence for a novel contribution to T1D risk, independent of the replicated effect of the R620W variant. Fifth, among the candidate genes selected for replication, the association of TCF7-P19T with T1D was newly replicated in this study. In summary, this study was able to replicate some genetic effects, reject others, and provide suggestions of association with several of the other candidate genes in stratified analyses (age at onset, HLA status, population of origin). These results have generated additional interesting functional hypotheses that will require further replication in independent cohorts.

Entities:  

Mesh:

Year:  2009        PMID: 19956109      PMCID: PMC2805447          DOI: 10.1038/gene.2009.99

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  48 in total

1.  Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.

Authors:  Hironori Ueda; Joanna M M Howson; Laura Esposito; Joanne Heward; Hywel Snook; Giselle Chamberlain; Daniel B Rainbow; Kara M D Hunter; Annabel N Smith; Gianfranco Di Genova; Mathias H Herr; Ingrid Dahlman; Felicity Payne; Deborah Smyth; Christopher Lowe; Rebecca C J Twells; Sarah Howlett; Barry Healy; Sarah Nutland; Helen E Rance; Vin Everett; Luc J Smink; Alex C Lam; Heather J Cordell; Neil M Walker; Cristina Bordin; John Hulme; Costantino Motzo; Francesco Cucca; J Fred Hess; Michael L Metzker; Jane Rogers; Simon Gregory; Amit Allahabadia; Ratnasingam Nithiyananthan; Eva Tuomilehto-Wolf; Jaakko Tuomilehto; Polly Bingley; Kathleen M Gillespie; Dag E Undlien; Kjersti S Rønningen; Cristian Guja; Constantin Ionescu-Tîrgovişte; David A Savage; A Peter Maxwell; Dennis J Carson; Chris C Patterson; Jayne A Franklyn; David G Clayton; Laurence B Peterson; Linda S Wicker; John A Todd; Stephen C L Gough
Journal:  Nature       Date:  2003-04-30       Impact factor: 49.962

2.  A functional variant of IRS1 is associated with type 1 diabetes in families from the US and UK.

Authors:  V Anne Morrison; Suna Onengut-Gumuscu; Patrick Concannon
Journal:  Mol Genet Metab       Date:  2004-04       Impact factor: 4.797

3.  Association of IL4R haplotypes with type 1 diabetes.

Authors:  Daniel B Mirel; Ana Maria Valdes; Laura C Lazzeroni; Rebecca L Reynolds; Henry A Erlich; Janelle A Noble
Journal:  Diabetes       Date:  2002-11       Impact factor: 9.461

4.  A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes.

Authors:  D Dubois-Laforgue; H Hendel; S Caillat-Zucman; J F Zagury; C Winkler; C Boitard; J Timsit
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

5.  Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans.

Authors:  M A Pani; M Knapp; H Donner; J Braun; M P Baur; K H Usadel; K Badenhoop
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

6.  Analysis of 55 autoimmune disease and type II diabetes loci: further confirmation of chromosomes 4q27, 12q13.2 and 12q24.13 as type I diabetes loci, and support for a new locus, 12q13.3-q14.1.

Authors:  J D Cooper; N M Walker; B C Healy; D J Smyth; K Downes; J A Todd
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

7.  A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.

Authors:  Nunzio Bottini; Lucia Musumeci; Andres Alonso; Souad Rahmouni; Konstantina Nika; Masoud Rostamkhani; James MacMurray; Gian Franco Meloni; Paola Lucarelli; Maurizio Pellecchia; George S Eisenbarth; David Comings; Tomas Mustelin
Journal:  Nat Genet       Date:  2004-03-07       Impact factor: 38.330

8.  Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos.

Authors:  Teodorica L Bugawan; Daniel B Mirel; Ana M Valdes; Araceli Panelo; Paolo Pozzilli; Henry A Erlich
Journal:  Am J Hum Genet       Date:  2003-05-13       Impact factor: 11.025

9.  A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes.

Authors:  Wafaa M Bassuny; Kenji Ihara; Yuka Sasaki; Ryuichi Kuromaru; Hitoshi Kohno; Nobuo Matsuura; Toshiro Hara
Journal:  Immunogenetics       Date:  2003-05-16       Impact factor: 2.846

10.  A polymorphism in the TCF7 gene, C883A, is associated with type 1 diabetes.

Authors:  Janelle A Noble; Amy M White; Laura C Lazzeroni; Ana M Valdes; Daniel B Mirel; Rebecca Reynolds; Andrew Grupe; Dee Aud; Gary Peltz; Henry A Erlich
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

View more
  8 in total

Review 1.  Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.

Authors:  Catherine D Mao; Stephen W Byers
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

2.  Overview of the Rapid Response data.

Authors:  W M Brown; J J Pierce; J E Hilner; L H Perdue; K Lohman; L Lu; P I W de Bakker; K Irenze; L Ziaugra; D B Mirel
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

3.  Overview of the Type I Diabetes Genetics Consortium.

Authors:  S S Rich; B Akolkar; P Concannon; H Erlich; J E Hilner; C Julier; G Morahan; J Nerup; C Nierras; F Pociot; J A Todd
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

4.  Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs.

Authors:  Grant Morahan; Munish Mehta; Ian James; Wei-Min Chen; Beena Akolkar; Henry A Erlich; Joan E Hilner; Cécile Julier; Jørn Nerup; Concepcion Nierras; Flemming Pociot; John A Todd; Stephen S Rich
Journal:  Diabetes       Date:  2011-01-24       Impact factor: 9.461

Review 5.  The pancreas in human type 1 diabetes.

Authors:  Patrick A Rowe; Martha L Campbell-Thompson; Desmond A Schatz; Mark A Atkinson
Journal:  Semin Immunopathol       Date:  2010-05-22       Impact factor: 9.623

6.  Receiver operating characteristic analysis of HLA, CTLA4, and insulin genotypes for type 1 diabetes.

Authors:  Ana M Valdes; Michael D Varney; Henry A Erlich; Janelle A Noble
Journal:  Diabetes Care       Date:  2013-04-29       Impact factor: 19.112

Review 7.  Precision medicine in diabetes prevention, classification and management.

Authors:  Fangying Xie; Juliana Cn Chan; Ronald Cw Ma
Journal:  J Diabetes Investig       Date:  2018-04-25       Impact factor: 4.232

8.  TCF1 and LEF1 Control Treg Competitive Survival and Tfr Development to Prevent Autoimmune Diseases.

Authors:  Bi-Huei Yang; Ke Wang; Shuo Wan; Yan Liang; Xiaomei Yuan; Yi Dong; Sunglim Cho; Wanqing Xu; Kristen Jepsen; Gen-Sheng Feng; Li-Fan Lu; Hai-Hui Xue; Wenxian Fu
Journal:  Cell Rep       Date:  2019-06-18       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.